Skip to content

Research Journal of Pharmacy and Technology

ISSN 0974-360X

4 papers in the library · publishing 2022-2026

Papers

Sort Most recent Most cited

Evaluation of Antioxidant and Antipsychotic Potential of Desmodium gangeticum on Ketamine-Induced Experimental Psychosis Model in Rats with a Focus on TNF-α Regulation

Research Journal of Pharmacy and Technology April 3, 2026 Rafiya Ahmadi, Pinki Verma

Aim: The present research is to evaluate the antioxidant and antipsychotic potential of Desmodium gangeticum on the ketamine-induced experimental psychosis model in rats with a focus on TNF-α Regulation. Materials and Methods: The root was collected, desiccated, and finely ground. Extraction was conducted using 98% ethanol in a Soxhlet apparatus. This study included a preliminary phytochemical...

Ayahuasca: Pharmacological Composition and Potential Benefits

Research Journal of Pharmacy and Technology October 1, 2025 Raj Nashikkar, Shrikrishna Baokar, Rajendra Patil

Ayahuasca is a traditional hallucinogenic concoction utilised by indigenous populations in the Amazon Basin for ages in spiritual and therapeutic rituals. The increasing global popularity is attributed to its alleged medicinal and consciousness-expanding properties. The infusion is primarily composed of two key components: the Banisteriopsis caapi vine and the leaves of Psychotria viridis,...

Evaluation of Ketamine after subacute low dosage Lipopolysaccharide-activated Microglia produced depressive-like phenotype in mice

Research Journal of Pharmacy and Technology April 22, 2024 Shuvranshu Praharaj, Vandurayanpet Kaliyamoorthy Kalaichelvan, Vedigounder Murugan et al.

Depression is a common mental illness, with an estimated 3.8% of global population affected. Peripheral administration of lipopolysaccharide (LPS) culminate in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in the forced swim test (FST) and anhedonia in sucrose preference tests (SPT). After 6 days of LPS stimulation, we established a depression...

Cerebrospinal Fluid Serotonin level as Biomarker for Neurotoxicity after 3,4-Methylenedioxymethamphetamine (MDMA)

Research Journal of Pharmacy and Technology August 30, 2022 Fatin H. Zakaria, Samhani Ismail, N.M.J Khadijah

A persistent 3,4-Methylenedioxymethamphetamine (MDMA) exposure may disrupt the human body serotonergic system which subsequently leads to physical and psychiatric chaos. Serotonin, a well-known monoamine neurotransmitter which is the main target of MDMA can be found in cerebrospinal (CSF) fluid. Its variation reflects the severity of neuronal damage caused by MDMA exposure. Hence, this article...